Cargando…
Can racial disparities in optimal gout treatment be reduced? evidence from a randomized trial
There is a disproportionate burden of gout in African-Americans in the U.S. due to a higher disease prevalence and lower likelihood of receiving urate-lowering therapy (ULT), compared to Caucasians. There is an absence of strong data as to whether the response to ULT differs by race/ethnicity. BMC M...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337326/ https://www.ncbi.nlm.nih.gov/pubmed/22316088 http://dx.doi.org/10.1186/1741-7015-10-15 |